Literature DB >> 14504928

Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells.

Shuy-Vang Toan1, Kenneth K W To, George P H Leung, Maria Olivia de Souza, Jeffrey L Ward, Chung-Ming Tse.   

Abstract

Human CNT3 encodes the concentrative nucleoside transport N3 system. Previous expression studies in oocytes showed that the Km values for nucleosides of the cloned hCNT3 were 7- to 25-fold lower than the endogenous N3 transporter in HL60 cells. Therefore, in the present study we re-examined the kinetic properties of the cloned hCNT3 using mammalian cell expression systems by transient expression in Cos7L cells and stably expression in nucleoside transporter deficient PK15NTD cells. We demonstrated that hCNT3 is a Na-dependent, broadly-selective nucleoside transporter with affinities (<11 microM) for nucleosides closely resembling the endogenous N3 transporter. Pharmacological studies showed that phloridzin is a mixed-type inhibitor of hCNT3 (Ki=15 microM), and the dideoxyuridine analogs are poor substrates. By epitope-tagging, we further demonstrated that hCNT3 is N-glycosylated as PNGase F and Endo H deglycosylated hCNT3 from 67 kDa to 58 kDa. Searching the human genome database, we identified the genomic organization of hCNT3. This gene contains 19 exons and its exon-intron boundaries within the coding sequence exactly match with those of hCNT1 and hCNT2 with one additional exon in the N-terminus. Our data suggest that hCNT3 gene is evolutionarily conserved with hCNT1 and hCNT2. Physiologically, hCNT3 is a glycoprotein, which transports purine and pyrimidine nucleosides in a Na-dependent manner with high affinities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504928     DOI: 10.1007/s00424-003-1166-0

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  37 in total

1.  Structure-inhibitory profiles of nucleosides for the human intestinal N1 and N2 Na+-nucleoside transporters.

Authors:  S D Patil; L Y Ngo; J D Unadkat
Journal:  Cancer Chemother Pharmacol       Date:  2000       Impact factor: 3.333

2.  Sodium-dependent nucleoside transport in the human intestinal brush-border membrane.

Authors:  S D Patil; J D Unadkat
Journal:  Am J Physiol       Date:  1997-06

3.  Molecular cloning of a Na+-dependent nucleoside transporter from rabbit intestine.

Authors:  K M Gerstin; M J Dresser; J Wang; K M Giacomini
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

4.  Mechanisms of transport of nucleosides and nucleoside analogues in choroid plexus.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-10-18       Impact factor: 15.470

5.  Characterization of a novel Na+-dependent, guanosine-specific, nitrobenzylthioinosine-sensitive transporter in acute promyelocytic leukemia cells.

Authors:  S A Flanagan; K A Meckling-Gill
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

6.  Kinetics and regulation of three cloned mammalian Na+/H+ exchangers stably expressed in a fibroblast cell line.

Authors:  S A Levine; M H Montrose; C M Tse; M Donowitz
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

7.  Subcellular distribution and membrane topology of the mammalian concentrative Na+-nucleoside cotransporter rCNT1.

Authors:  S R Hamilton; S Y Yao; J C Ingram; D A Hadden; M W Ritzel; M P Gallagher; P J Henderson; C E Cass; J D Young; S A Baldwin
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

8.  Na(+)/H(+) exchangers (NHE1-3) have similar turnover numbers but different percentages on the cell surface.

Authors:  M E Cavet; S Akhter; F S de Medina; M Donowitz; C M Tse
Journal:  Am J Physiol       Date:  1999-12

9.  Characterization of sodium-dependent and sodium-independent nucleoside transport systems in rabbit brush-border and basolateral plasma-membrane vesicles from the renal outer cortex.

Authors:  T C Williams; A J Doherty; D A Griffith; S M Jarvis
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

10.  Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines.

Authors:  J R Mackey; R S Mani; M Selner; D Mowles; J D Young; J A Belt; C R Crawford; C E Cass
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

View more
  8 in total

Review 1.  Loops and layers of post-translational modifications of drug transporters.

Authors:  Da Xu; Guofeng You
Journal:  Adv Drug Deliv Rev       Date:  2016-05-09       Impact factor: 15.470

2.  Host-based ribavirin resistance influences hepatitis C virus replication and treatment response.

Authors:  Kristie D Ibarra; Mamta K Jain; Julie K Pfeiffer
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

Review 3.  Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective.

Authors:  Syed Saqib Ali; Ruchika Raj; Tejinder Kaur; Brenna Weadick; Debasis Nayak; Minnsung No; Jane Protos; Hannah Odom; Kajal Desai; Avinash K Persaud; Joanne Wang; Rajgopal Govindarajan
Journal:  Cancers (Basel)       Date:  2022-06-25       Impact factor: 6.575

4.  Red fluorescent protein pH biosensor to detect concentrative nucleoside transport.

Authors:  Danielle E Johnson; Hui-Wang Ai; Peter Wong; James D Young; Robert E Campbell; Joseph R Casey
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

5.  Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance.

Authors:  Kristie D Ibarra; Julie K Pfeiffer
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

6.  Role of CNT3 in the transepithelial flux of nucleosides and nucleoside-derived drugs.

Authors:  Ekaitz Errasti-Murugarren; Marçal Pastor-Anglada; F Javier Casado
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

Review 7.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

8.  Homology Modeling of Human Concentrative Nucleoside Transporters (hCNTs) and Validation by Virtual Screening and Experimental Testing to Identify Novel hCNT1 Inhibitors.

Authors:  Hemant Kumar Deokar; Hilaire Playa Barch; John K Buolamwini
Journal:  Drug Des       Date:  2017-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.